MedPath

The Effect of Supplementation with Spirulina Algae on Growth Factor (VEGF) and Lipid Profile in Obese Individuals

Phase 2
Conditions
obesity.
obesity,unspecified
Registration Number
IRCT2015071219082N7
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

tendency to attend; obese individuals with BMI = 30 kg/m2; age group of 20 to 50.
Exclusion criteria: history of renal disease; history of CVD; cancers; acute infections; recent surgeries; usage of weight effective drugs (hormone drugs); antidepressant drugs; diuretic drugs; antibiotics; glucocorticoids; usage of any supplements in the past 3 months; pregnancy; breast feeding; menopause; following weight loss diets in 3 months before and during the intervention.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum vascular endothelial growth factor. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: ELISA.;Serum lipid profile. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: spectrophotometry,immunoturbidimetry.
Secondary Outcome Measures
NameTimeMethod
Energy intake, Macronutrients. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: 24 hours recall questionnaire.
© Copyright 2025. All Rights Reserved by MedPath